Abstract:"Just Accepted" papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content. Purpose To develop and validate a deep learning (DL) method to detect and segment enhancing and nonenhancing cellular tumor on pre- and posttreatment MRI scans of patients with glioblastoma and to predict overall survival (OS) and progression-free survival (PFS). Materials and Methods This retrospective study included 1397 MRIs in 1297 patients with glioblastoma, including an internal cohort of 243 MRIs (January 2010-June 2022) for model training and cross-validation and four external test cohorts. Cellular tumor maps were segmented by two radiologists based on imaging, clinical history, and pathology. Multimodal MRI with perfusion and multishell diffusion imaging were inputted into a nnU-Net DL model to segment cellular tumor. Segmentation performance (Dice score) and performance in detecting recurrent tumor from posttreatment changes (area under the receiver operating characteristic curve [AUC]) were quantified. Model performance in predicting OS and PFS was assessed using Cox multivariable analysis. Results A cohort of 178 patients (mean age, 56 years ± [SD]13; 121 male, 57 female) with 243 MRI timepoints, as well as four external datasets with 55, 70, 610 and 419 MRI timepoints, respectively, were evaluated. The median Dice score was 0.79 (IQR:0.53-0.89) and the AUC for detecting residual/recurrent tumor was 0.84 (95% CI:0.79- 0.89). In the internal test set, estimated cellular tumor volume was significantly associated with OS (hazard ratio [HR] = 1.04/mL, P < .001) and PFS (HR = 1.04/mL, P < .001) when adjusting for age, sex and gross total resection status. In the external test sets, estimated cellular tumor volume was significantly associated with OS (HR = 1.01/mL, P < .001) when adjusting for age, sex and gross total resection status. Conclusion A DL model incorporating advanced imaging could accurately segment enhancing and nonenhancing cellular tumor, classify recurrent/residual tumor from posttreatment changes, and predict OS and PFS in patients with glioblastoma. ©RSNA, 2024.

Deep learning for the automatic detection and segmentation of parotid gland tumors on MRI

Deep Learning-Based Multi-Modality Segmentation of Primary Gross Tumor Volume in CT and MRI for Nasopharyngeal Carcinoma.

Deep learning-assisted diagnosis of benign and malignant parotid gland tumors based on automatic segmentation of ultrasound images: a multicenter retrospective study

Deep Learning-Based Automatic Segmentation for Size and Volumetric Measurement of Breast Cancer on Magnetic Resonance Imaging.

Deep Learning-Assisted Diagnosis of Parotid Gland Tumors by Using Contrast-Enhanced CT Imaging.

Parotid Gland MRI Segmentation Based on Swin-Unet and Multimodal Images

deepPGSegNet: MRI-based pituitary gland segmentation using deep learning

Using Deep Learning to Distinguish Malignant from Benign Parotid Tumors on Plain Computed Tomography Images

Deep learning-assisted diagnosis of benign and malignant parotid tumors based on contrast-enhanced CT: a multicenter study

An anatomy-aware framework for automatic segmentation of parotid tumor from multimodal MRI

Parotid Gland Segmentation Using Purely Transformer-Based U-Shaped Network and Multimodal MRI

An Attention Base U-net for Parotid Tumor Autosegmentation.

Identifying Periampullary Regions in MRI Images Using Deep Learning

Deep Learning-Based Accurate Delineation of Primary Gross Tumor Volume of Nasopharyngeal Carcinoma on Heterogeneous Magnetic Resonance Imaging: A Large-Scale and Multi-Center Study.

Diagnostic performance of MRI-based radiomics models using machine learning approaches for the triple classification of parotid tumors

Automated Segmentation of the Parotid Gland Based on Atlas Registration and Machine Learning: A Longitudinal MRI Study in Head-and-Neck Radiation Therapy

Deep Learning Based Automatic Fibroglandular Tissue Segmentation in Breast Magnetic Resonance Imaging Screening

Differentiation of benign and malignant parotid gland tumors based on the fusion of radiomics and deep learning features on ultrasound images

Deep Learning Segmentation of Infiltrative and Enhancing Cellular Tumor on Pre- and Posttreatment Multishell Diffusion MRI of Glioblastoma

Development and Validation of a Deep Learning Model for Brain Tumor Diagnosis and Classification Using Magnetic Resonance Imaging

Using Machine Learning on MRI Radiomics to Diagnose Parotid Tumours Before Comparing Performance with Radiologists: A Pilot Study